MPN Advances Day 2017: latest updates in the field
Tackling CD47-positive malignancies
Efficacy of first generation FLT3 inhibitors for AML
Panel discussion on large cell lymphomas: subtypes, patient selection and mutations
Andrew Zelenetz et al.
Potential of next-generation sequencing in the NHS for patients with MPNs